Pioneer Surgical acquires NanoOss bone-growth technology

October 30, 2007 — Pioneer Surgical Technology Inc. (PST), has acquired Angstrom Medica Inc., a Woburn, Mass.-based developer of nanotechnology-based medical devices, according to a news release from the Marquette, Mich.-based PST.

Angstrom is the first company to obtain Food and Drug Administration (FDA) approval for a nanotechnology device — NanOss, Pioneer said in a news release. NanOss chemistries enable products that can remodel, over time, into human bone, with potential applications in trauma, spine and general orthopedic markets. Terms of the acquisition were not disclosed.

“Angstrom Medica and its innovative technology represent a strategic addition to the Pioneer family,” said Matthew N. Songer, Pioneer’s chairman and chief executive. “This latest orthobiologic acquisition complements our mission by developing technology that empowers surgeons to restore patients to normal function with products and methods not currently available.”

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.